Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest hypertension Stories

2013-06-05 12:31:19

HUNTSVILLE, Ala., June 5, 2013 /PRNewswire/ -- EGEN, Inc., a clinical stage biopharmaceutical company, announced today that EGEN's proprietary lung targeting Staramine-mPEG nanoparticle delivery system has been used to administer an inhibitor of microRNA-145 (anti-miRNA-145) in a rat model of severe occlusive PAH. Treatment was shown to significantly reverse the pulmonary hypertension associated with the advanced stages of the disease and restore cardiovascular function. This program, in...

2013-06-03 23:04:08

A rare disease can make a patient feel very alone -- just ask Kristen Wieneke of St. Franci, Wis. Meeting many others from around the country with the same lung disease has inspired her to plan a June 15 event to raise awareness and funds for the Pulmonary Hypertension Association. St. Francis, WI (PRWEB) June 03, 2013 A rare disease can make a patient feel very alone — just ask Kristen Wieneke of St. Francis. Wieneke had been living with a life-threatening lung disease, pulmonary...

2013-06-03 08:28:58

Sufferers Very Likely to Have Obstructive Sleep Apnea, Will Benefit from Treatment BALTIMORE, June 3, 2013 /PRNewswire/ -- The American Academy of Sleep Medicine (AASM) is advising anyone with Type 2 diabetes or hypertension to be evaluated for sleep apnea by a board-certified sleep medicine physician. The recommendation comes as the group of international clinicians and researchers meets in Baltimore for SLEEP 2013, the foremost gathering of sleep experts annually. Overwhelming...

2013-05-30 16:26:05

Program announces first round of participants TORONTO, May 30, 2013 /PRNewswire/ - The first three companies selected to participate in the MaRS EXCITE program aim to improve outcomes for breast cancer, sleep apnea and drug-resistant hypertension. The Excellence in Clinical Innovation and Technology Evaluation (EXCITE) initiative helps companies accelerate the adoption and reimbursement of innovative health technologies through a single, harmonized, pre-market, evidence-based...

2013-05-30 12:27:16

NORWALK, Conn., May 30, 2013 /PRNewswire/ -- About 78 million adults in the U.S. -- 1 out of every 3 -- has high blood pressure. And the prevalence of this potentially lethal condition is expected to continue to rise. Consultant Live attended the American Society of Hypertension (ASH) Meeting and presents a series of articles to help primary care physicians help their patients prevent high blood pressure, and to hone their treatment skills. Hypertension expert Gregory W. Rutecki, MD,...

2013-05-30 12:26:54

LONDON, May 30, 2013 /PRNewswire/ -- The World Stroke Organization will team with global medical technology leader Boston Scientific Corporation (NYSE:BSX), to further raise awareness and take action in the worldwide fight against stroke. "The WSO aims to reduce the global burden of stroke through prevention, acute treatment and long-term care," said WSO president Prof. Stephen Davis. Joining forces with Boston Scientific and other leading companies involved in the stroke...

2013-05-27 10:49:17

The news about youth and diabetes keeps getting worse. The latest data from the national TODAY diabetes study shows that children who develop Type 2 diabetes are at high risk to develop heart, kidney and eye problems faster and at a higher rate than people who acquire Type 2 diabetes as adults. "Once these kids have Type 2 diabetes, they seem to be at very high risk for early complications when compared to adults," said Jane Lynch, M.D., professor of pediatric endocrinology in the School...

2013-05-22 12:31:14

Interim Data from REDUCE-HTN Clinical Program Presented Today at EuroPCR PARIS, May 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today reported interim data from the REDUCE-HTN clinical program, which demonstrated a significant and sustained reduction in the blood pressure of patients treated with the Vessix(TM) Renal Denervation System. Data on the first 41 subjects enrolled in the REDUCE-HTN clinical program were presented today at the annual EuroPCR...

2013-05-17 23:15:13

Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, reports a new study that reveals a natural way to reduce stress, anxiety, and high blood pressure, and remedy insomnia. Toronto, ON (PRWEB) May 17, 2013 Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, reports a new study that reveals a natural way to reduce stress, anxiety, and high blood pressure, and remedy insomnia. As Bel Marra...

2013-05-17 23:01:17

Between May 17 and May 31, 2013, Dr. Avi Ishaaya will offer free screening and assessment for sleep apnea, an identifiable cause of hypertension. Los Angeles, CA (PRWEB) May 17, 2013 Dr. Avi Ishaaya, a nationally recognized sleep specialist and the founder of the I AM Sleep Program, specializing in portable home diagnosis and treatment of sleep apnea, will offer free sleep apnea assessments and $100 off the regular price of the home sleep test beginning May 17, World Hypertension Day, and...


Latest hypertension Reference Libraries

Hypertension (journal)
2012-05-14 11:48:30

Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...

More Articles (1 articles) »